CDMO Activity Tracker: Axplora enhances ADC capacities, Quotient beefs up HPAPI capabilities; Evonik, EUROAPI forge deals

Data Compilation
#PharmaFlow

Pipeline Prospector March 2025: Trump’s FDA overhaul spooks biotech stocks; Roche, AbbVie, Novo ink obesity drug deals

Stock Recap
#PipelineProspector

Clindamycin Phosphate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

41 API Suppliers, 18 USDMF, 12 CEP/COS, 6 JDMF, 1 EU WC, 2 KDMF, 13 NDC API, 17 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

20 Drugs in Development

20 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

169 FDF Dossiers, 133 FDA Orange Book, 10 Europe, 16 Canada, 1 South Africa, 9 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - EQ 300MG BASE/50ML (EQ 6MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 600MG BASE/50ML (EQ 12MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 900MG BASE/50ML (EQ 18MG BASE/ML), INJECTABLE;INJECTION - EQ 150MG BASE/ML, SOLUTION;TOPICAL - EQ 1% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, LOTION;TOPICAL - EQ 1% BASE, GEL;TOPICAL - EQ 1% BASE, GEL;TOPICAL - 5%;1.2%, GEL;TOPICAL - 5%;EQ 1% BASE, SUPPOSITORY;VAGINAL - 100MG, GEL;TOPICAL - EQ 1% BASE, CREAM;VAGINAL - EQ 2% BASE, AEROSOL, FOAM;TOPICAL - 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;TOPICAL - 1.2%;0.025%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Rochem International Inc, 3 SPI Pharma, 5 DKSH, 1 Pharm-RX Chemical, 1 Gangwal Healthcare, 10 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 8 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 13 BASF, 1 BioSpectra, 1 Clariant, 6 Corel Pharma Chem, 2 Finar, 7 Gangwal Chemicals, 8 Kerry, 5 Lubrizol Life Science Health, 4 Microlex e.U, 1 Nanjing Bold Chemical, 2 Pluviaendo, 16 Roquette, 10 Seppic, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

37 Topical, 24 Solubilizers, 23 Thickeners and Stabilizers, 23 Parenteral, 16 Film Formers & Plasticizers, 14 Emulsifying Agents, 13 Fillers, Diluents & Binders, 9 Coating Systems & Additives, 8 Surfactant & Foaming Agents, 8 Co-Processed Excipients, 7 Direct Compression, 7 Controlled & Modified Release, 6 Rheology Modifiers, 6 Lubricants & Glidants, 5 Taste Masking, 4 Granulation, 3 API Stability Enhancers, 2 Chewable & Orodispersible Aids, 1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 56 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 9 Regulatory FDF Prices

MARKET PLACE

32 APIs, 4 FDF Dossiers

PATENTS & EXCLUSIVITIES

21 US Patents, 2 US Exclusivities

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 2 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
28/03/2025	Sanofi	France	ROUSSELL UCLAF	13705	CLINDAMYCIN PHOSPHATE	1998-09-01	Inactive	II	N/A
28/03/2025	Sanofi	France	GENZYME CORP	13725	CLINDAMYCIN PHOSPHATE	1998-09-01	Inactive	II	N/A

Clindamycin Phosphate

Clindamycin Phosphate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

41 API Suppliers

18 USDMF

12 CEP/COS

6 JDMF

1 EU WC

2 KDMF

13 NDC API

17 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

20 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

169 FDF Dossiers

133 FDA Orange Book

10 Europe

16 Canada

1 South Africa

9 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - EQ 300MG BASE/50ML (EQ 6MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 600MG BASE/50ML (EQ 12MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 900MG BASE/50ML (EQ 18MG BASE/ML)

INJECTABLE;INJECTION - EQ 150MG BASE/ML

SOLUTION;TOPICAL - EQ 1% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

LOTION;TOPICAL - EQ 1% BASE

GEL;TOPICAL - EQ 1% BASE

GEL;TOPICAL - 5%;1.2%

GEL;TOPICAL - 5%;EQ 1% BASE

SUPPOSITORY;VAGINAL - 100MG

GEL;TOPICAL - EQ 1% BASE

CREAM;VAGINAL - EQ 2% BASE

AEROSOL, FOAM;TOPICAL - 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

GEL;TOPICAL - 1.2%;0.025%

RELATED EXCIPIENT COMPANIES

2 EUROAPI

2 Rochem International Inc

3 SPI Pharma

5 DKSH

1 Pharm-RX Chemical

1 Gangwal Healthcare

10 Nanjing Well Pharmaceutical

1 Pfanstiehl

8 Actylis

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

13 BASF

1 BioSpectra

1 Clariant

6 Corel Pharma Chem

2 Finar

7 Gangwal Chemicals

8 Kerry

5 Lubrizol Life Science Health

4 Microlex e.U

1 Nanjing Bold Chemical

2 Pluviaendo

16 Roquette

10 Seppic

1 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

1 Valens Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

37 Topical

24 Solubilizers

23 Thickeners and Stabilizers

23 Parenteral

16 Film Formers & Plasticizers

14 Emulsifying Agents

13 Fillers, Diluents & Binders

9 Coating Systems & Additives

8 Surfactant & Foaming Agents

SOLUTION;TOPICAL - EQ 1% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

AEROSOL, FOAM;TOPICAL - 1% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons